This study evaluates the diagnostic accuracy of the "bKIT Virus Finder COVID-19," a new point-of-care molecular test from Hyris Ltd., for detecting the SARS-CoV-2 virus. The test's performance was compared against the gold standard laboratory-based real-time RT-PCR methods using both retrospective and prospective analyses. Results showed a complete correlation between the Hyris kit and the reference methods for all analyzed samples, indicating high sensitivity and specificity. The system provides reliable results in less than two hours without requiring a fully equipped laboratory. The study concluded that this point-of-care test is a promising and accurate tool to improve health surveillance and significantly increase SARS-CoV-2 testing capacity.